Literature DB >> 16263830

Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults.

Deborah A Elder1, Ronald L Prigeon, R Paul Wadwa, Lawrence M Dolan, David A D'Alessio.   

Abstract

CONTEXT: Type 2 diabetes mellitus (T2DM) is estimated to account for 10-45% of incident pediatric diabetes cases.
OBJECTIVE: Our objective was to characterize the metabolic defects underlying T2DM in adolescents and young adults. DESIGN, SETTING, AND PATIENTS: We conducted a cross-sectional study of islet function and insulin sensitivity in 16 adolescents with T2DM and 13 obese (OB) and 13 lean (LN) age-matched nondiabetic subjects at a University Medical Center. INTERVENTION: We provided oral and iv glucose tolerance tests. MAIN OUTCOME MEASURES: We measured insulin and glucagon levels, insulin sensitivity, acute insulin responses to iv glucose, and the ratio of proinsulin to immunoreactive insulin.
RESULTS: The diabetic subjects had elevated fasting insulin levels and significantly reduced insulin sensitivity (P < 0.05). The acute insulin response to iv glucose was comparable in the T2DM and LN groups (P < 0.05 for the OB vs. LN and T2DM), but insulin secretion adjusted for insulin resistance, the disposition index, was severely impaired in the diabetic subjects (P < 0.05 for the T2DM vs. LN and OB). The ratio of proinsulin to immunoreactive insulin did not differ among the three groups in the basal or stimulated state. Plasma glucagon levels were comparable before and after ingestion of glucose.
CONCLUSIONS: These findings demonstrate that diabetic adolescents have significant insulin resistance, even compared with subjects of similar obesity and body fatness, and impaired insulin secretion relative to their degree of insulin resistance. However, the adolescent diabetic subjects retained a first-phase insulin response to glucose that was comparable to lean controls and did not have hyperproinsulinemia or hyperglucagonemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263830     DOI: 10.1210/jc.2005-0853

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1.

Authors:  Jenny Tong; Harold W Davis; Amalia Gastaldelli; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

2.  Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.

Authors:  Yi-Ching Tung; Jing-Sheng Lee; Wen-Yu Tsai; Pei-Hung Hsiao
Journal:  Eur J Pediatr       Date:  2007-09-15       Impact factor: 3.183

3.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

4.  Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

Authors:  Deborah A Elder; Jessica G Woo; David A D'Alessio
Journal:  Pediatr Diabetes       Date:  2010-08       Impact factor: 4.866

5.  Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.

Authors:  Marzieh Salehi; Torsten P Vahl; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

6.  Tetrahydroindenoindole inhibits the progression of diabetes in mice.

Authors:  Howard G Shertzer; Scott N Schneider; Eric L Kendig; Deborah J Clegg; David A D'Alessio; Elisabet Johansson; Mary Beth Genter
Journal:  Chem Biol Interact       Date:  2008-09-07       Impact factor: 5.192

7.  Effects of exercise training intensity on pancreatic beta-cell function.

Authors:  Cris A Slentz; Charles J Tanner; Lori A Bateman; Michael T Durheim; Kim M Huffman; Joseph A Houmard; William E Kraus
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

8.  Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Steven E Kahn; David E Cummings; Matthias H Tschöp; David D'Alessio
Journal:  Diabetes       Date:  2010-06-28       Impact factor: 9.461

9.  The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?

Authors:  Benedikt A Aulinger; Torsten P Vahl; Ron L Prigeon; David A D'Alessio; Deborah A Elder
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-15       Impact factor: 4.310

10.  Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.

Authors:  Hala Tfayli; Fida Bacha; Neslihan Gungor; Silva Arslanian
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.